Literature DB >> 3104986

Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.

D Collen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3104986

Source DB:  PubMed          Journal:  Prog Hemost Thromb        ISSN: 0362-6350


× No keyword cloud information.
  4 in total

1.  Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing.

Authors:  K A Houston; D I McRitchie; O D Rotstein
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

2.  Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma.

Authors:  P Kristensen; C Pyke; L R Lund; P A Andreasen; K Danø
Journal:  Histochemistry       Date:  1990

Review 3.  New strategies in the development of thrombolytic agents.

Authors:  H R Lijnen; D Collen
Journal:  Blut       Date:  1988-10

4.  Indications for thrombolytic therapy in acute pulmonary embolism.

Authors:  J A Dieck; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.